-+ 0.00%
-+ 0.00%
-+ 0.00%

According to Zhitong Finance App News, Tengsheng Pharmaceutical-B (02137.HK) announced the end of treatment (EOT) and follow-up results of its Phase IIb ENRICITY and ENHANCE study in the form of three latest breakthrough reports at the American Society for Liver Disease Research (AASLD) Liver Disease Annual Meeting® held in Denver, Colorado, USA from November 5 to 9, 2026.

Zhitongcaijing·11/05/2026 23:41:17
Listen to the news
According to Zhitong Finance App News, Tengsheng Pharmaceutical-B (02137.HK) announced the end of treatment (EOT) and follow-up results of its Phase IIb ENRICITY and ENHANCE study in the form of three latest breakthrough reports at the American Society for Liver Disease Research (AASLD) Liver Disease Annual Meeting® held in Denver, Colorado, USA from November 5 to 9, 2026.